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Patient satisfactionPurpose: Telehealth (TH) in Radiation Oncology at Townsville Cancer Centre (TCC) was implemented in
July 2011 to provide cancer care closer to home to the regional and rural population. The aim of this study
was to describe the service use and patient satisfaction.
Materials and methods: A retrospective audit of records was conducted for patients treated at TCC
between July 2011 and December 2015. Data included patient demographics, diagnosis and treatment.
Results of a patient satisfaction survey were summarised through descriptive statistics.
Results: A total of 1530 TH consultations were provided to 833 patients. 311 patient charts were audited
(615 TH, 650 in-person, 151 phone consultations). Median distance from TCC to satellites was 327.3 km
(21.6 to 1130.1). 71% were male and median age was 65 (23–94 years). Cancer diagnoses included pros-
tate (32%), breast (12%) and head and neck (10%). 60% of patients underwent radiation therapy for cura-
tive intent, 22% palliative and 18% did not undergo treatment. 106 patients participated in the satisfaction
survey (231 patients invited, response rate of 46%), with the overall positive response mainly attributed
to advantages in travel and time savings. 54.7% of patients selected TH as their preference for future con-
sultations, 34.9% indicated a mix of TH and in-person consultations, and only 1 patient (0.9%) indicating
in-person only.
Conclusion: TH enables the delivery of radiation oncology consultations to rural and regional patients,
with an overall high level of patient satisfaction. Patients welcomed the model for benefits of travel
and time savings. Future directions include engaging with specialist, rural medical staff and patients to
maximize access.
 2018 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and
Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
There is a well-documented disparity in outcomes between
rural and urban locations across health. This has been repeatedly
shown in the field of Oncology, where it has been demonstrated
that rural Australians with cancer are 35% more likely to die within
5 years of diagnosis compared to those in cities [1]. This risk
increases with greater distance from a major city [2]. This is ampli-
fied in Indigenous Australians residing in regional and rural Aus-
tralia, where cancer mortality rates are up to 45% higher than in
the non-Indigenous population [1,3].
Factors contributing to poor outcomes have been identified as
restricted access to diagnostic and treatment services including
specialist services, lower socioeconomic status, cost of travel,physical accessibility in terms of distance to tertiary services, late
diagnosis, and lifestyle and environmental factors such as higher
rates of alcohol and smoking, reduced physical activity and
increased sun exposure [2,4].
This disparity in health outcomes has also been demonstrated
in the field of Radiation Oncology. Studies have shown that mortal-
ity risk increases by 6% for each 100 km increment in distance from
the nearest radiotherapy facility [5]. Furthermore, access to radia-
tion oncology in regional centres is limited, and only 11 of 157
regional chemotherapy administering centres reporting radiation
oncology services [6]. This is of particular concern considering
one in every two patients with cancer is likely to require radiation
in their course of treatment.
Initiatives to improve outcomes in oncology care in regional
and rural Australia include the Australian government funded
Regional Cancer Centre (RCC) Initiative in 2010, where 26 rural
cancer centres were provided with considerable additional funding
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care coordination. This includes the use of nursing care coordina-
tors working within a multidisciplinary team, and nurse practition-
ers, to promote shared care models in rural regions [7].
Telemedicine is another major model of care designed to
improve access to specialist cancer care in rural populations and
will be the focus of this report. Telemedicine, also referred to as
telehealth (TH), provides patient consultations with a specialist
facilitated through video-conferencing rather than a face-to-face
consultation. The benefits of telemedicine include increased access
to health professionals, efficiency in reducing time and travel
expenses, access to multiple remote sites in one session, and spe-
cialist support for rural health workers allowing up-skilling [8].
Importantly, both patients and clinicians have reported satisfaction
with the quality of service it allows including supporting effective
communication [9]. Several models of telehealth in oncology have
been developed to provide medical and allied health consultations,
facilitate multidisciplinary team meetings, case conference discus-
sions and tumour board meetings, supervise chemotherapy admin-
istration and remote planning of radiotherapy treatment [10–15].
Tele-radiation oncology at Townsville Cancer Centre (TCC) in
North Queensland, Australia was implemented in July 2011 with
an aim of providing consultations closer to home for its geograph-
ically dispersed rural and regional patients to reduce the burden of
long-distance travel. Townsville has a population of approximately
200 000 people and is the key tertiary public centre for a popula-
tion of 670 000 people in North Queensland. This referral area
extends north to Cape York Peninsula and the Torres Strait Islands,
and west to Mount Isa and the Gulf of Carpentaria, with patients
travelling as far as 1200 km to receive treatment. Since its imple-
mentation, the service has grown to include regular tele-
radiation oncology new and review clinics between TCC and its
rural satellite sites.2. The tele-radiation oncology model
The tele-radiation oncology model was developed following the
success of the tele-oncology model in medical oncology at TCC
[10]. The Radiation Oncologist (RO) provides both new and review
consultations to the satellite sites to suitable patients via videocon-
ferencing. Where a new consultation takes place via TH, the RO will
explain the treatment options and rationale, and review relevant
medical history and pathology. A physical examination and formal
written consent is obtained face-to-face when the patient attends
for their simulation for radiation therapy. If there are any contra-
indications to radiation therapy found at the face-to-face review,
the simulation will not proceed. Therefore, all TH patients coming
for radiation therapy will meet their RO face-to-face prior to sim-
ulation and commencing radiation therapy treatment. Patients
deemed suitable for tele-radiation oncology follow-up consults
are those where recurrence is detected via medical imaging or
pathology (e.g. prostate cancer), and not by physical examination.
Where physical examinations are required (e.g. breast cancer), the
patient will be offered alternate TH and face-to-face follow up
appointments, with a physical exam by the General Practitioner
(GP) or medical officer requested at TH reviews.
The TH hardware (Tandberg 990 codecs (Polycom, California,
USA) and Sony Bravia 32-inch LCD monitors (Sony, Tokyo, Japan))
is portable, and thus can be transported to the clinic room. The
patient at the rural site attends their local hospital, health facility
or GP offices, or more recently, can download an application on
their tablet or smart phone. These rural facilities require a broad-
band internet connection and a webcam with microphone and
speaker to participate. TCC has a dedicated telehealth coordinator
to facilitate appointment bookings and logistics with the ruralsites, with each appointment booked at the equivalent of a face-
to-face consult (usually 10–30 min, depending on the type of the
appointment).
Literature on tele-radiation oncology is limited in relation to
models of care and outcomes for radiation oncology patients from
rural areas. Whilst broadly, telehealth has been shown to have
clear benefits in oncology with high rates of patient satisfaction,
it is unclear if this can also be applied to Radiation Oncology given
its requirement for highly technological equipment, necessitating
specialised regional centres for radiation therapy treatment deliv-
ery, and thus travel associated with treatment itself. There is, how-
ever, a recognised need to leverage communication and
information technology to achieve greater cancer control outcomes
and decrease disparities whilst maintaining patient satisfaction
and engagement [16,17]. Therefore, the aim of this report is to
describe the utility of tele-radiation oncology at TCC along with
an assessment of patient satisfaction of this model of care.3. Methodology
3.1. Study design and setting
The study was conducted at Townsville Hospital, a 600-bed ter-
tiary regional hospital in North Queensland. The tele-radiation
oncology program is an initiative of the Townsville Cancer Centre
(TCC) implemented in July 2011. All patients who participated in
the tele-radiation oncology TH program between July 2011 and
July 2015 were identified through tracing TH billing codes for
appointments.3.2. Participants and eligibility criteria
Patients were eligible to participate in the tele-radiation oncol-
ogy TH program at TCC if the patient was willing and had access to
local TH facilities, and were deemed suitable clinically by the radi-
ation oncologist and/or referring specialist. Adults aged 18 years
and over, with any disease type and treatment intent, were eligible.
Both new and follow up or review appointments were included.
Initially data from all patients who received radiation therapy
was analysed to describe the overall use of TH compared to other
types of appointments.
Subsequently, given that the focus of this paper was to evaluate
patient satisfaction and to demonstrate the feasibility of rolling out
a model like this in a large geographical area, a sample of 311 TH
patients were selected for deeper analysis of geographical dis-
tances. This was achieved by selection of every third patient in
chronological order, to gain a representative sample over time.
For missing data, further details were sought from the MOSAIQ
records, including radiation prescription, clinic notes and appoint-
ment schedules. Patients who had inpatient appointments or
phone appointments only were not included in this further
descriptive analysis.3.3. Data collection and measurement
The selected patient charts were audited to collect the following
variables: basic patient demographics (including gender, age, post-
code and Aboriginal or Torres Strait Islander status); disease infor-
mation including cancer type, staging and treatment intent
(curative including curative adjuvant or neoadjuvant, or palliative
intent); and appointment type (new consultation or follow-up).
The total number of radiation oncology TH appointments by type
and year was also recorded, to enable detailed description of the
TH service.
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ment 1) based on previous Medical Oncology satisfaction surveys
[9,18]. The survey was posted to a convenience sample of patients
(n = 231) with a postage-paid envelope to return, or completed
over telephone with an administrative officer during the period
of 2011–2015. Participants were approached sequentially in the
survey timeframe, with the only eligibility criteria being that they
had a TH consultation within the survey timeframe. Telephone
calls were made to all non-responders to maximise responses. In
addition to collecting basic demographics, the survey asked partic-
ipants to rate satisfaction using Likert-type scales over a number
of domains with the following questions: I could see the Doctor
clearly (Vision); I could hear the Doctor clearly (Audio); I felt
my privacy and confidentiality were respected (Privacy); I felt I
could ask questions and seek clarification openly and easily with
(Questions); I found it easy to establish rapport with my oncolo-
gist (Rapport); I felt it reassuring to have a nurse or local doctor
with me for my consultation (Accompany); I felt my diagnosis
and treatment options could be adequately explained (Explana-
tion). Participants ranked the importance of possible advantages
around cost, time, travel and family, and provided their prefer-
ences for future consultations (face-to-face; TH or a combination
of both). A free text question offered the participants opportunity
to feedback any further issues not already covered by the survey.
Demographics and rating/ranking questions were analysed using
descriptive statistics. The free text responses were analysed for
emerging themes.3.4. Statistical methods
Data was de-identified and analysed through descriptive statis-
tics using Rstudio software Version 1.1.383 [19]. Qualitative writ-
ten responses were analysed through thematic coding.3.5. Ethics
Approval as a quality improvement project was granted by the
Townsville Hospital and Health Services (THHS) Human Research
Ethics Committee (HREC) Chairperson.4. Results
4.1. Overall radiation oncology service
In the study period between July 2011 to 2015, there was a total
of 5247 patients who attended any form of radiation oncology
appointment (in person, phone or TH, total of 17 397 appoint-
ments). 833 (15.9%) of these patients attended 1530 (8.8%) tele-
radiation oncology appointments Fig. 1. There were 305 ‘new’
(19.9%) and 1225 (80%) ‘follow up’ TH consults. 4766 patients
attended 14,370 in-person consults, where 3738 (26%) of these
were new appointments and 10,632 (74%) were follow up. 804
patients had a total of 1497 phone consults (8.5% of total).4.2. Demographic data
Of the 311 patients selected for further analysis, 221 (71.1%)
were male and 90 (28.9%) were female with a median age of
65 years (range 23–94 years). The patients lived in 63 different
postcode areas and accessed TTH radiation oncology service from
a mean distance of 402.9 km from Townsville hospital (range
21.6–1130.1 km). 7.1% of patients analysed identified as Aboriginal
or Torres Strait Islander.4.3. Details of tele-radiation oncology services
The 311 patients included for analysis attended a total of 1416
appointments of all types in the study period. Of these, 615 (43.3%)
were TH appointments, where 37.1% were new and 62.9% were fol-
low up appointments. 650 of these appointments (45.9%) were in-
person with a mean of 2 appointments per patient and 151 (10.7%)
were phone consults, with a mean of one appointment per patient
(range 0–8). 6.4% of patients identified as Aboriginal and/or Torres
Strait Islander.
Prostate cancer was the most common cancer type in this
cohort (32%, n = 100); followed by breast (12% n = 36); Head and
neck (10%, n = 32); lung (9%, n = 28); rectal (9%, n = 28); skin (8%,
n = 25); and other cancers (20%, n = 62), including oesophagus,
colon, cervix, uterine, bladder, thyroid, brain, myeloma, follicular
lymphoma and secondary or malignancy unspecified cancers. The
treatment intent was 60% curative (37% curative, 18% curative
adjuvant, 5% neoadjuvant), 22% palliative intent and 18% did not
undergo radiation therapy treatment.
4.4. Survey results
The survey response rate was 106 out of 231 patients (45.8%),
including 12 (11%) completed by telephone. The mean age was
65 years (44–88), and 54% were male (see Table A.1 for detailed
demographic details). For future consultation preferences, 54.7%
of patients (n = 58) nominated Telehealth consultations only,
0.9% (1 patient) nominated face to face only consultations, and
34.9% (n = 37) preferred mixed modality of both TH and face to
face. 9.4% (n = 10) preferences for future consults were unknown.
4.5. Satisfaction
The satisfaction responses using the Likert scale are sum-
marised in Fig. 2.
4.6. Ranking
45 respondents (42%) answered the ranking question in the
intended manner, ranking all 4 elements in the order of impor-
tance to them with 1 being most important, 4 being least impor-
tant (Table 1). 58% of patients did not answer the question
correctly, so were excluded from results.
Four key themes emerged from free text analysed: 1) overall
satisfaction and preferences; 2) communication and rapport, and
technology; 3) efficiencies; and 4) shared care and carer support
(Table A.2). While there was overall satisfaction, there was a mixed
preference reported with some respondents indicating they saw
value in face-to-face visits in addition to the TH consultations.
Feedback regarding the communication, rapport and technology
again showed a mixed response, with some indicating difficulties
in audio quality or patient hearing difficulties. There was an overall
benefit noted in efficiencies in travel, time and cost, as well as
reduction in disruptions to work and family life. One key benefit
noted by many respondents was the ability for a family member
or carer to sit in on the TH consultation.5. Discussion
Our study demonstrates that radiation oncology consultations
can be provided to patients from rural and regional centres using
a tele-radiation oncology model of care in a manner that is accept-
able to patients. Patient satisfaction was high, reflected by prefer-
ence for future consultations to be solely via TH (54.7%) or a mixed
model of TH and face-to-face consultations (34.9%).
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explained by the large proportion of patients being treated for
prostate cancer. This high proportion is reflective of the clinical
practice profile of two of the radiation oncologists most active in
TH, and patient suitability. The TH program was accessed by
patients of all ages (range 23–94 years), with a median age of
65 years. The program was also culturally accessible, with 6.4% ofpatients of the subgroup examined identifying as being Aboriginal
or Torres Strait Islander.
The median distance that patients lived from Townsville hospi-
tal was 402.9 km. The largest distance recorded was 1130 km, in a
remote community. This is significant for several reasons, includ-
ing financial savings in terms of transport and accommodation,
in addition to social and emotional factors implicated when
Table 1
Patient response to telehealth advantages in patient satisfaction survey.
Advantage Mean rankingy n = 45
Travel saving 1.9
Time saving 2.3
Cost saving 2.8
Reduced family interruption 3.1
y Ranked from 1 to 4 from most important (1) to least important (4).
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and family. It also enables the presence of the patients’ support
networks more consistently throughout treatment. Furthermore,
the tele-radiation oncology program is inclusive in that there is
no exclusion based on location. For example, patients residing on
Magnetic Island, a 20-minute ferry ride from Townsville mainland,
could utilize this service. This demonstrates that use of TH even for
more local patients is an option that could be explored, which may
minimize time required out of daily activities and time spent in
waiting rooms.
A range of diseases were managed through tele-radiation oncol-
ogy at TCC for all kinds of treatment intents. The most common
cancers included prostate (32%), breast (12%) and head and neck
(10%), and treatment was usually with curative intent (60%), with
22% of patients analysed being managed with palliative intent.
An advantage of TH being accessible to palliative patients is that
patient wishes can be prioritized, remaining in their home town
with family or friends towards the end of life.
Overall, the tele-radiation oncology service represented a small
percentage of the overall number of appointments (9%). Further-
more, there has been a comparatively low uptake of TH between
2011 and 2015, as a portion of overall radiation oncology appoint-
ments, as demonstrated in Fig. 1. This highlights the need for the
health system to take ownership of the TH model, incorporating
it as core business across all professional streams, as demonstrated
by our medical oncology colleagues [20]. Confirmation of the appli-
cability and patient satisfaction through this work serves to advo-
cate the continued uptake of the tele-oncology model both locally
and further abroad.
Telehealth consults are usually ‘‘review” or follow-up appoint-
ments, rather than initial appointments. This may reflect the physi-
cian’s requirement to complete a full physical examination and
carry out relevant investigations in this initial consultation, which
can then inform appropriateness of utilizing future radiation
oncology appointments. Alternatively, patients are not being iden-
tified as candidates for TH appointments prior to their initial con-
sultation. Given the physician directed eligibility criteria, it is
unclear whether patients are being effectively captured as possible
candidates for TH, and given the option to participate. To improve
this, a clear check box to indicate whether the patient is eligible for
TH (completed by the referring physician, and confirmed by the
RO), and subsequently if they would like to participate, would be
useful information to gather on initial referral (and on subsequent
appointments where eligibility may change). Increasing patient
and physician awareness and engagement of the program is also
an important strategy.
Due to the significant infrastructure requirements, the low pop-
ulation density (3.1 people per square kilometre) and remote geo-
graphical challenges of Australia, there will be always be a travel
requirement to attend specialised radiation oncology facilities for
rural and remote patients, as radiotherapy centres will remain con-
centrated in regional and metropolitan centres [21,22]. While the
model of care in tele-radiation oncology differs to that of tele-
medical oncology as patients are still required to travel for radia-
tion therapy treatment, the benefit of initial and follow up consul-
tations via TH is reflected in the overwhelming preference forfuture consultations to be at least in part utilising the tele-
radiation oncology model of care.
The positive patient satisfaction results demonstrate acceptabil-
ity of TH consultations, as supported by previous studies in Medi-
cal Oncology [9,18]. The survey highlighted the acceptability of the
visual and audio quality, with issues only arising in 4% and 6% of
respondents respectively. Other benefits noted was the rapport
and relationship between the specialist and the patient, and subse-
quent information sharing. The lower satisfaction scoring when
asked if the presence of a nurse or local doctor provided reassur-
ance indicates that the role of the clinician on the patient’s side
may need to be clarified further with the patient.
Key limitations of the satisfaction response survey were both
the low number of patients invited to participate, and the response
rate of 45.8%. There may have been important differences in
patients not captured in the survey, meaning that we may have
overestimated patient satisfaction and missed potential telehealth
problems. While there is potential for self-motivated bias, the
demographics of those responding to the survey indicate an accu-
rate representation of the population presenting to radiation
oncology at TCC.
Furthermore, one sub-section of the survey was incorrectly
interpreted by 58% of patients, who rated each question from 1
to 4, rather than ranking in preference order. The wording of this
question should be amended for future use. There is also a recog-
nised potential for positive response bias in answering of the sur-
veys via telephone, however this was mitigated through an
administrative officer completing the survey with the patient
rather than a medical treatment team member.
The process for identifying technical issues with TH was incon-
sistent and dependent on accurate reporting by radiation oncology
physicians, potentially resulting in an underestimation of TH
issues. A process for consistent and streamlined reporting of TH
issues could help provide a more accurate estimation for future
analysis and improvement of services.
The key limitation of this report is its descriptive nature with no
assessment of patient outcomes, or toxicity data. However, during
chart review, we did not identify any documented concerns by the
radiation oncologists.6. Conclusions
Overall this descriptive analysis of the tele-radiation oncology
program at TCC suggests that telehealth has broad applicability
to patients of all ages, with a wide range of cancers, with both cura-
tive and palliative intent. Notably, the program serviced patients
living in regional, rural and remote Queensland, saving patients
both travel and time expenses, while maintaining patient
satisfaction.
Initiatives could be put in place to promote the awareness of
this program to patients and to rural general practitioners and
medical centres, in addition to TCC continuing to incorporate the
model as core business. Expansion of the program also relies on
engagement, training and up-skilling of medical staff in rural areas.
Further focus should be placed on providing culturally appropriate
Telehealth appointments to Aboriginal and Torres Strait Islander
patients, such as through involving Indigenous Health Liaison Offi-
cers. Analysis on the impact of tele-radiation oncology has on
patient outcomes at our centre is also important, to facilitate fur-
ther expansion of the program.Conflicts of interest
No conflicts of interest to declare.
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